Atom
Dashboard
Favorites
Profile
Atom
Sign In
Get Started
Back
Drug Development RFP
Rolling Submissions
Alzheimer's Drug Discovery Foundation (ADDF)
$5,000,000
Description
Support for investigational new drug (IND)-enabling studies and early-phase clinical trials testing promising interventions for Alzheimer's disease and related dementias Letter of Intent due on various dates in 2024
Award Ceiling
$5,000,000
Eligible Applicants
- Researchers and clinicians worldwide at academic medical centers
- universities
- nonprofits
- and biotechnology companies
Funding Type
Grant
Categories of Funding Activity
- Science, Technology, and Research & Development
- Health
Grantor Contact Information
Aaron Burstein, PharmD, Head of Search & Evaluation aburstein@alzdiscovery.org
Additional information
The Drug Development RFP supports investigational new drug (IND)-enabling studies (or the international equivalent) and early-phase clinical trials that test promising pharmacological interventions and devices for Alzheimer’s disease (AD) and related dementias.
Supporting Link
https://www.alzdiscovery.org/research-and-grants/funding-opportunities/drug-development-rfp
Start finding grants with Atom for
$0 today
$30 Billed monthly after 7-day trial. Cancel anytime.
Personalized grant emails delivered weekly, right to your inbox.
AI powered search engine with both keyword and semantic search capabilities.
Grant filters to find the perfect funding opportunities.
Get Started
